Anteris Technologies (AVR) - חוב לטווח ארוך להון

This price chart, serving as confirmation of the market valuation, demonstrates the price action of Anteris Technologies Global (AVR), where the indicator stands at 0.01. Anteris Technologies Global (AVR) develops proprietary heart prosthetics, whose DurAVR technology guarantees stable B2B orders and growth in free cash flow. Current medical testing costs are temporarily creating negative leverage; however, biomimetic developments are strengthening the brand's authority among surgeons, restoring quality of life for patients.

Anteris Technologies Global is investing in the development of high-tech heart valve bioprostheses, which requires significant long-term funding during the R&D phase. By analyzing the ratio of long-term debt to equity, the investor assesses the company's reliance on external loans with maturities exceeding one year relative to its equity, where an upward trend signals increasing leverage and financial risks.